Polyamine deprivation prevents the development of tumour-induced immune suppression

British Journal of Cancer

Volumn 76, Issue 3, 1997, Pages 365-370

  Chamaillard, L ^a   Catros Quemener, V ^a,c   Delcros, J G ^a   Bansard, J Y ^a   Havouis, R ^a   Desury, D ^a   Commeurec, A ^b   Genetet, N ^b   Moulinoux, J P ^a  

^a Inst de Recherche Contre le Cancer   (France)

^b Faculté de Médecine   (France)

^c CNRS   (France)

Author keywords

Immune suppression; Interleukin 2; Polyamine; T lymphocyte

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; METRONIDAZOLE; NEOMYCIN; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; OXIDOREDUCTASE INHIBITOR; POLYAMINE; POLYAMINE OXIDASE;

ARTICLE; CANCER GRAFT; CANCER IMMUNOLOGY; CELL METABOLISM; DIET; IMMUNOSUPPRESSIVE TREATMENT; LEWIS CARCINOMA; LUNG CARCINOMA; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; T LYMPHOCYTE;

EID: 0030790243     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.391     Document Type: Article

References (29)

1. Bowlin TL, McKown BJ and Sunkara PS (1987) The effect of α-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on mitogen-induced interleukin 2 production. Immunopharmacology 13: 143-147
2. Chamaillard L, Quemener V, Havouis R and Moulinoux J-PH (1993) Polyamines deprivation stimulates natural killer cell activity in cancerous mice. Anticancer Res 13: 1027-1034
3. Flescher E, Bowlin TL and Talal N (1989) Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells. J Immunol 142: 907-912
4. Flescher E, Bowlin TL and Talal N (1992) Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids. Clin Exp Immunol 87: 435-437
5. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, Ogawa N and Talal N (1994) Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 153: 4880-4889
6. Gillis S, Ferm MM, Ou W and Smith KA (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120: 2027-2032
7. Heby O (1989) Polyamines and cell differentiation. In The Physiology of Polyamines, Bachrach U and Heimer YM (eds) pp. 83-94. CRC Press: Boca Raton (FL)
8. Hessels J, Kingma AW, Ferwerda H, Keij J, Berg GAVD and Muskiet FAJ (1989) Microbial flora in the gastrointestinal tract abolishes cytostatic effects of α-difluoromethylornithine in vivo. Int J Cancer 43: 1155-1164
9. Hessels J, Kingma AW, Muskiet FAJ, Sarhan S and Seiler N (1991) Growth inhibition of two solid tumors in mice, caused by poly amine depletion, is not attended by alterations in cell-cycle phase distribution. Int J Cancer 48: 697-703
10. Hölttä E (1985) Polyamine requirement for polyribosome formation and protein synthesis in human lymphocytes. In Recent Progress in Polyamine Research, Selmeci L, Brosnan ME and Seiler N (eds). pp. 137-150. Akadémiai Kiadò: Budapest
11. 2 in tumor bearing mice. Boll 1st sieroter milan 64: 25-34
12. Mamont PS, Duchesne M-C, Grove J and Bey P (1978) Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81: 58-66
13. Mills GB, Cheung RK, Grinstein S and Gelfand EW (1985) Increase in cytosolic free calcium concentration is an intracellular messenger for the production of interleukin 2 but not for expression of the interleukin 2 receptor. J Immunol 134: 1640-1643
14. Moulinoux J-PH, Quemener V. Larzul J-J, Calve ML, Roch A-M, Toujas L and Quash G (1984) Red blood cell polyamines in mice bearing the Lewis lung carcinoma (3LL) and in patients with bronchopulmonary cancers. Int J Cancer 34: 277-281
15. Moulinoux J-PH, Darcel F, Quemener V, Havouis R and Seiler N (1991a) Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation. Anticancer Res 11: 175-180
16. Moulinoux J-PH, Quemener V, Cipolla B, Guillé F, Havouis R, Martin C, Lobel B and Seiler N (1991b) The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation. J Urol 146: 1408-1412
17. 2-dependent and independent immune suppressor cells by tumor-derived GM-CST and M-CSF. J Leukoc Biol 53: 86-92
18. Pegg AE (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262
19. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759-774
20. Quemener V, Moulinoux J-PH, Bergeron C, Darcel F, Cipolla B, Denais A, Havouis R, Martin C and Seiler N (1992) Tumor growth inhibition by polyamine deprivation. In Polyamines in the Gastrointestinal Tract, Dowling. Folsch and Loser (eds), pp. 375-385. Kluwer Academic Press: Lancaster, UK
21. Rudkin BB, Mamont PS and Seiler N (1984) Decreased protein-synthetic activity is an early consequence of spermidine depletion in rat hepatoma tissue-culture cells. Biochem J 217: 731-741
22. Sarhan S, Knödgen B and Seiler N (1989) The gastrointestinal tract as polyamine source for tumor growth. Anticancer Res 9: 215-224
23. Seiler N and Atanassov CL (1994) The natural polyamines and the immune system. In Progress in Drug Research. Jucker E (ed.), pp. 87-141. Birkhäuser: Basle Switzerland
24. Seiler N, Sarhan S, Grauffel C, Jones R, Knödgen B and Moulinoux J-PH (1990) Endogenous and exogenous polyamines in support of tumor growth. Cancer Res 50: 5077-5083
25. Tabor CW and Tabor H (1984) Polyamines. Ann Rev Biochem 53: 749-790
26. Thomas TJ, Gunnia UB and Thomas T (1992) Reversal of the abnormal development of T cell subpopulations in the thymus of autoimmune MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor. Autoimmunity 13: 275-283
27. Thomas T, Gunnia UB, Yurkov. EJ, Seibold JR and Thomas TJ (1993) Inhibition of calcium signalling in murine splenocytes by polyamines: differential effects on CD4 and CD8 T-cells. Biochem J 291: 375-381
28. Young MRI and Wright MA (1992) Myclopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: γ interferon plus tumor necrosis factor α synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Cancer Res 52: 6335-6340
29. Young MR, Newby M and Meunier J (1985) Relationships between morphology, dissemination, migration, and prostaglandin E, secretion by cloned variants of Lewis lung carcinoma. Cancer Res 45: 3918 3923